Cholera Vaccines; Work group introduction; Public Comment; Vote; Zoster Vaccine; Update on post-licensure safety monitoring of recombinant

zoster vaccine (RZV, Shingrix) in the Vaccine Adverse Event

Reporting System (VAERS); Vaccine Safety Datalink (VSD) update on post-licensure safety monitoring of RZV; Risk of Guillain-Barré syndrome following herpes zoster; Summary and planned risk-benefit analysis regarding use of RZV in immunocompetent adult; Planned risk-benefit analysis regarding use of RZV in immunocompetent adults

Comments on this video are allowed in accordance with our comment policy:

http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html

This video can also be viewed at

https://www.cdc.gov/vaccines/videos/low-res/acipoct2020/5_Chloera-Vote-Zoster_LowRes.mp4

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.